Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Shares Outstanding (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Shares Outstanding for 3 consecutive years, with $53.5 million as the latest value for Q4 2020.

  • On a quarterly basis, Shares Outstanding rose 2.96% to $53.5 million in Q4 2020 year-over-year; TTM through Dec 2020 was $53.5 million, a 2.96% increase, with the full-year FY2020 number at $53.5 million, up 2.96% from a year prior.
  • Shares Outstanding was $53.5 million for Q4 2020 at Precision Biosciences, roughly flat from $53.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $53.5 million in Q4 2020 to a low of $16.5 million in Q1 2018.
  • A 3-year average of $38.0 million and a median of $51.4 million in 2019 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: grew 2.04% in 2019, then skyrocketed 209.87% in 2020.
  • Precision Biosciences' Shares Outstanding stood at $22.0 million in 2018, then skyrocketed by 136.68% to $52.0 million in 2019, then increased by 2.96% to $53.5 million in 2020.
  • Per Business Quant, the three most recent readings for DTIL's Shares Outstanding are $53.5 million (Q4 2020), $53.3 million (Q3 2020), and $53.0 million (Q2 2020).